Opioid use in advanced malignant disease: why do different centers use vastly different doses? A plea for standardized reporting

Journal of Pain and Symptom Management
M Boisvert, S R Cohen

Abstract

This paper reviews several recent publications concerning the use of opioids to control cancer pain and highlights the wide variation in mean daily dose. Present methods of reporting do not provide an explanation for these widely different doses used. It is essential that we understand the circumstances in which high doses are required, as higher doses are associated with greater toxicity and higher cost. Several factors that may influence the dose of opioid required are discussed. It is suggested that reporting of cancer pain, patient population, pharmacological and nonpharmacological interventions, and toxicity be standardized to allow for rational guidelines to be established for opioid use in pain due to advanced cancer.

References

Dec 1, 1978·The American Journal of Nursing·A S ValentineM Weintraub
Sep 1, 1978·Journal of Medical Ethics·R G Twycross
Oct 24, 1992·Lancet·J S MorleyD Bowsher
May 8, 1992·Science·E P WiertelakL R Watkins
Jul 1, 1992·Journal of Pain and Symptom Management·S A SchugB Stobbe
Feb 1, 1990·Physiology & Behavior·K J Sufka, R A Hughes
Apr 1, 1985·The Journal of Nervous and Mental Disease·R F CatchloveL A Demers-Desrosiers
Jun 19, 1993·BMJ : British Medical Journal·C E Pither, J Ralphs
Feb 20, 1993·BMJ : British Medical Journal·D Bowsher

❮ Previous
Next ❯

Citations

Mar 6, 2008·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Robin L Fainsinger, Cheryl L Nekolaichuk
Nov 1, 1996·Journal of Pain and Symptom Management·P WalkerA Taube
Nov 1, 1996·Journal of Pain and Symptom Management·S Mercadante
Jun 4, 1999·Journal of Pain and Symptom Management·R de WitH H Abu-Saad
May 28, 1998·Journal of Pain and Symptom Management·S Mercadante
May 7, 2003·The Lancet Oncology·Nigel Sykes, Andrew Thorns
Jul 23, 2003·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Susannah HallDouglas Wescules
Mar 25, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Robin L Fainsinger, Cheryl L Nekolaichuk
Mar 23, 2005·Journal of Pain and Symptom Management·Robin L FainsingerAntonio Vigano
May 21, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Robin L FainsingerJohn Hanson
Mar 17, 2009·Palliative Medicine·A K KnudsenS Kaasa
Apr 27, 2019·Palliative Medicine·Katrin Ruth SigurdardottirDagny Faksvåg Haugen
Apr 15, 2009·Current Opinion in Supportive and Palliative Care·Marianne J HjermstadUNKNOWN European Palliative Care Research Collaborative (EPCRC)
Apr 12, 2000·Cancer Control : Journal of the Moffitt Cancer Center·S Mercadante
Mar 6, 2009·Current Opinion in Supportive and Palliative Care

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved